Poster Station 2 (Rideau Canal Atrium) Moderator: Maryam Nouri
P.010 - Interim efficacy and safety results from the ongoing phase 3 CHAMPION-NMOSD trial of ravulizumab in adults with AQP4-Ab+ NMOSD P.011 - Measuring cord blood b cells in neonates with possible exposure in utero to Anti-B cell therapies P.013 - Psychosocial Impact of COVID-19 pandemic among Omanis with Multiple Sclerosis: a single tertiary center experience P.014 - Decision-making in the use of corticosteroids for treating multiple sclerosis relapses: a retrospective study from a single Canadian center P.015 - Analysis of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibodies using live cell-based assay in a reference laboratory with over 6,000 tests P.016 - Secondary immunodeficiencies in ocrelizumab - versus rituximab-treated persons with relapsing Multiple Sclerosis P.017 - EBNA1 titres are elevated in radiologically isolated syndrome and correlate with plasma GFAP P.018 - 24-year-old woman post-partum with subacute paresthesias and facial diplegia
.png)
